The association of nutritional and inflammatory biomarkers with overall survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors.

I M HorstmanP C VinkeE Suazo-ZepedaT J N HiltermannM A HeuvelmansE CorpeleijnGeertruida H de Bock

Published in: Thoracic cancer (2024)

These results highlight the potential value of nutritional and inflammatory biomarkers, in particular CAR and PNI, in identifying NSCLC patients with highest mortality risk before starting ICI treatment.

Keyphrases

oxidative stress
small cell lung cancer
advanced non small cell lung cancer
combination therapy
free survival
newly diagnosed
brain metastases
epidermal growth factor receptor
tyrosine kinase
smoking cessation